Literature DB >> 22641043

Hepatitis: New doubts about preventing HAV superinfection in chronic HCV.

Daniel Shouval.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 22641043     DOI： 10.1038/nrgastro.2012.103

Source DB:  PubMed          Journal:  Nat Rev Gastroenterol Hepatol        ISSN： 1759-5045            Impact factor:   46.802


× No keyword cloud information.
  8 in total

Review 1.  Evolving epidemiology of hepatitis C virus.

Authors:  D Lavanchy
Journal:  Clin Microbiol Infect       Date:  2011-02       Impact factor: 8.067

2.  Mortality of hepatitis A in adults with hepatitis C antibodies.

Authors:  G Hasle; T Hoel; M Jensenius
Journal:  Lancet       Date:  1998-06-20       Impact factor: 79.321

3.  Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.

Authors:  S Vento; T Garofano; C Renzini; F Cainelli; F Casali; G Ghironzi; T Ferraro; E Concia
Journal:  N Engl J Med       Date:  1998-01-29       Impact factor: 91.245

Review 4.  Acute hepatitis A and acquired immunity to hepatitis A virus in hepatitis B virus (HBV) carriers and in HBV- or hepatitis C virus-related chronic liver diseases in Thailand.

Authors:  C Pramoolsinsap
Journal:  J Viral Hepat       Date:  2000-05       Impact factor: 3.728

Review 5.  Fulminant hepatitis associated with hepatitis A virus superinfection in patients with chronic hepatitis C.

Authors:  S Vento
Journal:  J Viral Hepat       Date:  2000-05       Impact factor: 3.728

6.  Cost-effectiveness of hepatitis A vaccination for individuals with chronic hepatitis C.

Authors:  Michael K Chapko; Helen S Yee; Alexander Monto; Jason A Dominitz
Journal:  Vaccine       Date:  2009-12-29       Impact factor: 3.641

Review 7.  Cost-effectiveness analyses of hepatitis A vaccine: a systematic review to explore the effect of methodological quality on the economic attractiveness of vaccination strategies.

Authors:  Andrea M Anonychuk; Andrea C Tricco; Chris T Bauch; Ba' Pham; Vladimir Gilca; Bernard Duval; Ava John-Baptiste; Gloria Woo; Murray Krahn
Journal:  Pharmacoeconomics       Date:  2008       Impact factor: 4.981

8.  Hepatitis A virus vaccination in persons with hepatitis C virus infection: consequences of quality measure implementation.

Authors:  Ian A Rowe; Richard Parker; Matthew J Armstrong; Diarmaid D Houlihan; David J Mutimer
Journal:  Hepatology       Date:  2012-06-11       Impact factor: 17.425
  8 in total
  1 in total

Review 1.  Molecular biology and inhibitors of hepatitis A virus.

Authors:  Yannick Debing; Johan Neyts; Hendrik Jan Thibaut
Journal:  Med Res Rev       Date:  2013-05-30       Impact factor: 12.944
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.